LULY JAY R. (President and CEO) received a stock award from ENANTA PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/13/2026ACC: 0002064832-26-000006
DirectorOfficer· President and CEO
Since Jul 2018
+13.85K
Net shares
Net buyer
$87.7K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
20K acquired · 6.16K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+4.80K
Price / share
—
Trade value
—
% of position
0.6%
2/12/2026
858.03K→862.83K
Common Stock
Direct
Shares
+15.20K
Price / share
—
Trade value
—
% of position
1.8%
2/12/2026
862.83K→878.03K
Common Stock
Direct
Shares
−6.16K
Price / share
$14.25
Trade value
$87.71K
% of position
0.7%
2/12/2026
878.03K→871.87K
Total
Net shares
+13.85K
Net value
-$87.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2026 | A · Award | +4.80K | — | — | 0.6% | 858.03K | 862.83K |
| Common Stock Direct | 2/12/2026 | A · Award | +15.20K | — | — | 1.8% | 862.83K | 878.03K |
| Common Stock Direct | 2/12/2026 | F · Tax Withholding | −6.16K | $14.25 | $87.71K | 0.7% | 878.03K | 871.87K |
| Total | +13.85K | -$87.71K | ||||||
Derivative Transactions0
No derivative transactions reported